Protalix biotherapeutics price target
Webb16 mars 2024 · H.C. Wainwright raised the price target for the Protalix BioTherapeutics Inc. (AMEX:PLX) stock to "a Buy". The rating was released on June 08, 2024, according to finviz. We previously noted in another research note published on April 17, 2024 by Rodman & Renshaw that reiterated the stock to a Buy with a price target of Webb28 mars 2024 · PROTALIX BIOTHERAPEUTICS INC : News, information and stories for PROTALIX BIOTHERAPEUTICS INC TEL AVIV STOCK EXCHANGE: TEL AVIV STOCK EXCHANGE. Advanced search Log in. Forgot ... HC Wainwright Adjusts Price Target o.. MT. More recommendations: Press releases: 03/22:
Protalix biotherapeutics price target
Did you know?
WebbProtalix BioTherapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. PLX.IL updated stock price target summary. Webb6 apr. 2024 · Protalix BioTherapeutics - PLX - Stock Price Today - Zacks Protalix BioTherapeutics (PLX) (Delayed Data from AMEX) $2.21 USD +0.07 (3.27%) Updated Apr 6, 2024 04:00 PM ET After-Market: $2.20...
Webb10 apr. 2024 · The latest price target for . Protalix BioTherapeutics (AMEX: PLX) was reported by HC Wainwright & Co. on Monday, May 3, 2024.The analyst firm set a price target for 7.00 expecting PLX to rise to ... Webb26 maj 2024 · PROTALIX BIOTHERAPEUTICS, INC. (PLX) ... 34% Higher Than YTD Asset Prices • FNQ • Apr 13, 2024 7:00 AM. MONI Signs Binding MOU With a Part 135 Air Charter Company to Acquire 100% of MONI • MONI • Apr 12, 2024 10:00 AM. Start posting your company's news ...
WebbReset. Adjust the short trade & breakdown. Price Cover Loss % Target 1 Profit % P/L ratio: 5.4:1 (Excellent) Target 2 Profit % P/L ratio: 6.3:1 (Excellent) Trade $ Save Shares Base Loss % Save Risk $ 9706 or 4130 shares at 3.4 % … Webb12 apr. 2024 · 52-week price history of PLX Stock. Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Protalix BioTherapeutics Inc.’s current trading price is 6.28% away from its 52-week high, while its distance from the 52-week low is 154.10%.
WebbProtalix Pipeline Home / Pipeline Pipeline Overview Our pipeline consists of proprietary, potentially clinically superior versions of recombinant therapeutic proteins that target established pharmaceutical markets. All of our pipeline candidates are proteins expressed via our proprietary ProCellEx ® system.
WebbFör 1 dag sedan · Stock Price Forecast. According to 5 stock analysts, the average 12-month stock price forecast for PLX stock is $ 11.22 , which predicts an increase of 398.67%. The lowest target is $ 11.11 and the highest is $ 11.55. On average, analysts … cheap us ticketsWebbProtalix BioTherapeutics Reports Fiscal Year 2024 Financial and Business Results. Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein … cycle routes brightonWebb12 sep. 2013 · Protalix BioTherapeutics, Inc., a corporation organized under the laws of Florida (the “Company”), proposes to issue and sell to the several parties named in Schedule I hereto (the “Initial Purchasers”), for whom you (the “Representatives”) are acting as representatives, U.S.$60,000,000 principal amount of its 4.50% Convertible Notes due … cheap us vacation package deals 2 nightsWebb10 apr. 2024 · Protalix BioTherapeutics Inc. (AMEX:PLX)’s beta value is currently sitting at 1.43, while the Average True Range indicator is currently displaying 0.12. With analysts … cheap us tickets airWebb13 apr. 2024 · Protalix BioTherapeutics Inc. (AMEX:PLX) shares, rose in value on Wednesday, 04/12/23, with the stock price up by 3.83% to the previous day’s close as strong demand from buyers drove the stock to $2.44. Actively observing the price movement in the last trading, the stock closed the session at $2.35, falling within a range … cheap us tickets from indiaWebb30 juni 2024 · Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx plant cell-based protein expression system, today reported financial results for … cycle routes bridgwaterWebb27 feb. 2024 · Evolution of the average Target Price on PROTALIX BIOTHERAPEUTICS, INC. Target Price consensus revisions : last 18 months: Recommendations (Chart) PROTALIX BIOTHERAPEUTICS, INC. Analyst Recommendations on PROTALIX BIOTHERAPEUTICS, INC. 2024: Protalix BioTherapeutics : HC ... cheap us whiskey rye containing english notes